SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VINCENZI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.935
AS - Asia 8.977
EU - Europa 5.129
SA - Sud America 1.548
AF - Africa 222
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 31.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.546
SG - Singapore 3.321
CN - Cina 2.166
IT - Italia 1.293
BR - Brasile 1.213
VN - Vietnam 1.094
DE - Germania 815
HK - Hong Kong 698
UA - Ucraina 547
GB - Regno Unito 475
TR - Turchia 437
PL - Polonia 436
FI - Finlandia 380
FR - Francia 313
BD - Bangladesh 270
JP - Giappone 231
CA - Canada 220
SE - Svezia 216
RU - Federazione Russa 206
IN - India 201
ID - Indonesia 151
AR - Argentina 118
MX - Messico 116
NL - Olanda 98
ZA - Sudafrica 88
IQ - Iraq 62
ES - Italia 56
BE - Belgio 50
CO - Colombia 50
EC - Ecuador 49
AT - Austria 48
PK - Pakistan 44
LT - Lituania 41
UZ - Uzbekistan 41
VE - Venezuela 38
MY - Malesia 33
CZ - Repubblica Ceca 31
SA - Arabia Saudita 30
MA - Marocco 27
KE - Kenya 26
AE - Emirati Arabi Uniti 25
CL - Cile 25
TN - Tunisia 24
CH - Svizzera 23
PH - Filippine 22
PY - Paraguay 20
KR - Corea 17
EG - Egitto 16
JO - Giordania 16
IE - Irlanda 15
IL - Israele 15
BO - Bolivia 13
AU - Australia 12
CR - Costa Rica 12
DZ - Algeria 12
NP - Nepal 12
PE - Perù 11
ET - Etiopia 10
PT - Portogallo 10
TW - Taiwan 10
UY - Uruguay 10
HN - Honduras 9
EU - Europa 8
IR - Iran 8
KZ - Kazakistan 8
BG - Bulgaria 7
JM - Giamaica 7
KG - Kirghizistan 7
LV - Lettonia 7
PS - Palestinian Territory 7
TH - Thailandia 7
AL - Albania 6
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
HU - Ungheria 6
RO - Romania 6
RS - Serbia 6
GR - Grecia 5
PA - Panama 5
SY - Repubblica araba siriana 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CG - Congo 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
NO - Norvegia 4
OM - Oman 4
AM - Armenia 3
CY - Cipro 3
GE - Georgia 3
KW - Kuwait 3
MK - Macedonia 3
NI - Nicaragua 3
PR - Porto Rico 3
AO - Angola 2
BF - Burkina Faso 2
Totale 31.800
Salva come PNG Salva come JPEG
Città #
Singapore 2.094
Ashburn 2.019
Fairfield 1.189
Woodbridge 1.155
San Jose 1.083
Chandler 795
Beijing 760
Houston 742
Ann Arbor 709
Hong Kong 679
Santa Clara 678
Jacksonville 619
Seattle 502
Wilmington 472
Cambridge 421
Warsaw 419
Ferrara 370
Los Angeles 354
Ho Chi Minh City 344
New York 293
Dallas 284
Hanoi 267
Munich 248
Izmir 236
Tokyo 216
Council Bluffs 206
Nanjing 169
Helsinki 167
Princeton 163
Lauterbourg 162
Milan 142
Shanghai 136
São Paulo 123
Boardman 119
Jakarta 117
San Diego 109
Orem 107
Buffalo 99
Turku 90
London 82
Chicago 72
The Dalles 70
Chennai 68
Bologna 66
Frankfurt am Main 66
Montreal 66
Mexico City 64
Toronto 63
Tianjin 62
Da Nang 58
Bremen 57
Denver 57
Brooklyn 55
Nanchang 53
Johannesburg 51
Shenyang 49
Brussels 47
Dearborn 47
Stockholm 45
Hefei 43
San Francisco 43
Atlanta 42
Haiphong 41
Manchester 41
Phoenix 41
Boston 38
Moscow 37
Hebei 36
Nuremberg 36
Tashkent 36
Jiaxing 35
Rome 35
Falls Church 34
Falkenstein 33
Poplar 33
Amsterdam 32
Changsha 31
Rio de Janeiro 31
Columbus 30
Belo Horizonte 28
Ankara 25
Auburn Hills 24
Norwalk 24
Washington 24
Zhengzhou 24
Brno 23
Curitiba 22
Dong Ket 22
Baghdad 21
Biên Hòa 21
Des Moines 21
Guangzhou 21
Mountain View 21
Porto Alegre 21
Zurich 19
Augusta 18
Brasília 18
Hải Dương 18
Medellín 18
Florence 17
Totale 21.233
Salva come PNG Salva come JPEG
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 414
Pharmacology of Adenosine Receptors: The State of the Art 398
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 302
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 299
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 296
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 289
The A3 adenosine receptor: history and perspectives 285
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 284
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 284
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 277
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 276
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 275
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 273
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 270
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 264
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 261
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 260
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 257
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 256
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 254
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 254
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 253
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 244
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 242
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 242
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 238
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 236
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 234
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 225
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 222
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 222
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 221
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 219
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 217
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 215
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 215
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 215
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 212
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 211
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 208
Pathological overproduction: the bad side of adenosine 208
Targeting A3 and A2A adenosine receptors in the fight against cancer 208
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 203
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 203
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 203
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 201
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 200
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 200
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 200
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 198
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 197
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 196
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 195
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 194
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 193
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 192
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 190
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 188
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 184
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 182
Development of novel pyridazinone-based adenosine receptor ligands 182
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 181
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 180
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 177
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 176
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 175
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 174
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 174
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 172
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 172
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 172
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E2 and cytokine production in human osteoarthritic synovial fibroblasts 171
Effects of pulsed electromagnetic field exposure on adenosine receptors in human fibroblast-like synoviocytes. 170
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. 169
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 169
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 168
The role of adenosine receptors in rheumatoid arthritis. 167
A2A adenosine receptors and chronic caffeine intake in human neutrophils 166
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 166
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 165
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 165
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 163
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition (dagger). 163
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 163
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 162
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases 160
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 159
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 159
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 159
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 159
L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter 158
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 157
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 157
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 157
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 155
Effect of Pulsed Electromagnetic Field Exposure on Adenosine Receptors in Human Fibroblast-like Synoviocytes 155
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 155
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 154
Behavioral and binding studies on the quinolinyl ester indoles 5F-PB22 (5F-QUPIC) and BB-22 (QUCHIC) in the mouse model 153
Totale 20.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.405
Totale 141.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 0 0 135
2021/20221.497 46 155 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20255.044 109 151 374 288 469 510 241 284 803 515 695 605
2025/202613.662 1.329 544 1.110 1.570 2.017 926 1.558 773 1.273 1.535 690 337
Totale 32.251